Literature DB >> 29842983

eIF4A2 is a host factor required for efficient HIV-1 replication.

Jerry Kwame Ndzinu1, Hiroaki Takeuchi2, Hideki Saito1, Takeshi Yoshida1, Shoji Yamaoka3.   

Abstract

Host factors are required for efficient HIV-1 replication. To identify these factors, genome-wide RNA interference screening was performed using a human T cell line. In the present study, we assessed whether eukaryotic translation initiation factor 4A isoform 2 (eIF4A2), a DEAD-box protein identified in our screen, is necessary for efficient HIV-1 replication. Exploiting MT4C5 cells depleted of eIF4A2 by stable expression of eIF4A2-specific short-hairpin RNA (shRNA) using a lentiviral system, we found that depletion of eIF4A2 markedly inhibited the infection of a replication-competent reporter HIV-1. eIF4A2 depletion reduced the efficiency of viral cDNA synthesis with virion entry into target cells being unaffected. Depletion of eIF4A2 also inhibited HIV-1 spreading infection in a knockdown level-dependent manner. These results suggest that HIV-1 requires eIF4A2 for optimal replication in human T cells.
Copyright © 2018 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  DEAD-box protein; HIV-1; Host factor; RNAi; Viral cDNA synthesis; eIF4A2

Mesh:

Substances:

Year:  2018        PMID: 29842983     DOI: 10.1016/j.micinf.2018.05.001

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  9 in total

Review 1.  DEAD-ly Affairs: The Roles of DEAD-Box Proteins on HIV-1 Viral RNA Metabolism.

Authors:  Shringar Rao; Tokameh Mahmoudi
Journal:  Front Cell Dev Biol       Date:  2022-06-13

2.  Molecular Antiretroviral Resistance Markers of Human Immunodeficiency Virus-1 of CRF01_AE Subtype in Bali, Indonesia.

Authors:  Nyoman Sri Budayanti; Tuti Parwati Merati; Budiman Bela; Gusti Ngurah Mahardika
Journal:  Curr HIV Res       Date:  2018       Impact factor: 1.581

3.  MicroRNA-5195-3p enhances the chemosensitivity of triple-negative breast cancer to paclitaxel by downregulating EIF4A2.

Authors:  Mei Liu; Can Gong; Renyuan Xu; Yu Chen; Xiaodong Wang
Journal:  Cell Mol Biol Lett       Date:  2019-07-01       Impact factor: 5.787

4.  EIF4A2 interacts with the membrane protein of transmissible gastroenteritis coronavirus and plays a role in virus replication.

Authors:  Zhenhui Song; Yang Yang; Li Wang; Kai Wang; Ling Ran; Yilu Xie; LeiShi Huang; Zhou Yang; Peng Yuan; Qiuhan Yu
Journal:  Res Vet Sci       Date:  2018-12-17       Impact factor: 2.534

Review 5.  Phosphorylation Targets of DNA-PK and Their Role in HIV-1 Replication.

Authors:  Andrey Anisenko; Marina Kan; Olga Shadrina; Anna Brattseva; Marina Gottikh
Journal:  Cells       Date:  2020-08-16       Impact factor: 6.600

Review 6.  Application of CRISPR-Cas9 Gene Editing for HIV Host Factor Discovery and Validation.

Authors:  William J Cisneros; Daphne Cornish; Judd F Hultquist
Journal:  Pathogens       Date:  2022-08-09

7.  Copy number variation of EIF4A2 loci related to phenotypic traits in Chinese cattle.

Authors:  Zijing Zhang; Mengyang Peng; Yifan Wen; Yanan Chai; Juntong Liang; Peng Yang; Xian Liu; Jungang Li; Yajun Huang; Lijuan Li; Weihong Huang; Zengfang Qi; Guojie Yang; Fuying Chen; Qiaoting Shi; Zhiming Li; Baorui Ru; Chuzhao Lei; Eryao Wang; Yongzhen Huang
Journal:  Vet Med Sci       Date:  2022-09-02

8.  Upper airway gene expression differentiates COVID-19 from other acute respiratory illnesses and reveals suppression of innate immune responses by SARS-CoV-2.

Authors:  Eran Mick; Jack Kamm; Angela Oliveira Pisco; Kalani Ratnasiri; Jennifer M Babik; Carolyn S Calfee; Gloria Castañeda; Joseph L DeRisi; Angela M Detweiler; Samantha Hao; Kirsten N Kangelaris; G Renuka Kumar; Lucy M Li; Sabrina A Mann; Norma Neff; Priya A Prasad; Paula Hayakawa Serpa; Sachin J Shah; Natasha Spottiswoode; Michelle Tan; Stephanie A Christenson; Amy Kistler; Charles Langelier
Journal:  medRxiv       Date:  2020-05-19

9.  Upper airway gene expression reveals suppressed immune responses to SARS-CoV-2 compared with other respiratory viruses.

Authors:  Eran Mick; Jack Kamm; Angela Oliveira Pisco; Kalani Ratnasiri; Jennifer M Babik; Gloria Castañeda; Joseph L DeRisi; Angela M Detweiler; Samantha L Hao; Kirsten N Kangelaris; G Renuka Kumar; Lucy M Li; Sabrina A Mann; Norma Neff; Priya A Prasad; Paula Hayakawa Serpa; Sachin J Shah; Natasha Spottiswoode; Michelle Tan; Carolyn S Calfee; Stephanie A Christenson; Amy Kistler; Charles Langelier
Journal:  Nat Commun       Date:  2020-11-17       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.